This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rutledge, E. A.
Right arrow Articles by Russell, D. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rutledge, E. A.
Right arrow Articles by Russell, D. W.

 Previous Article  |  Next Article 

J. Virol., Jan 1998, 309-319, Vol 72, No. 1
Copyright © 1998, American Society for Microbiology

Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2

EA Rutledge, CL Halbert and DW Russell
Division of Hematology and Markey Molecular Medicine Center, University of Washington, Seattle 98195, USA.

Adeno-associated viruses (AAVs) are single-stranded dependent parvoviruses being developed as transducing vectors. Although at least five serotypes exist (AAV types 1 to 5 [AAV1 to -5]), only AAV2, AAV3, and AAV4 have been sequenced, and the vectors in use were almost all derived from AAV2. Here we report the cloning and sequencing of a second AAV3 genome and a new AAV serotype designated AAV6 that is related to AAV1. AAV2, AAV3, and AAV6 were 82% identical at the nucleotide sequence level, and AAV4 was 75 to 78% identical to these AAVs. Significant sequence variation was noted in portions of the capsid proteins that presumably are responsible for serotype-specific functions. Vectors produced from AAV3 and AAV6 differed from AAV2 vectors in host range and serologic reactivity. The AAV3 and AAV6 vector serotypes were able to transduce cells in the presence of serum from animals previously exposed to AAV2 vectors. Our results suggest that vectors based on alternative AAV serotypes will have advantages over existing AAV2 vectors, including the transduction of different cell types, and resistance to neutralizing antibodies against AAV2. This could be especially important for gene therapy, as significant immunity against AAV2 exists in human populations and many protocols will likely require multiple vector doses.


This article has been cited by other articles:

  • Mays, L. E., Vandenberghe, L. H., Xiao, R., Bell, P., Nam, H.-J., Agbandje-McKenna, M., Wilson, J. M. (2009). Adeno-Associated Virus Capsid Structure Drives CD4-Dependent CD8+ T Cell Response to Vector Encoded Proteins. J. Immunol. 182: 6051-6060 [Abstract] [Full Text]  
  • Hewitt, F. C., Li, C., Gray, S. J., Cockrell, S., Washburn, M., Samulski, R. J. (2009). Reducing the Risk of Adeno-Associated Virus (AAV) Vector Mobilization with AAV Type 5 Vectors. J. Virol. 83: 3919-3929 [Abstract] [Full Text]  
  • Schmidt, M., Govindasamy, L., Afione, S., Kaludov, N., Agbandje-McKenna, M., Chiorini, J. A. (2008). Molecular Characterization of the Heparin-Dependent Transduction Domain on the Capsid of a Novel Adeno-Associated Virus Isolate, AAV(VR-942). J. Virol. 82: 8911-8916 [Abstract] [Full Text]  
  • Stone, D., Liu, Y., Li, Z.-Y., Strauss, R., Finn, E. E., Allen, J. M., Chamberlain, J. S., Lieber, A. (2008). Biodistribution and Safety Profile of Recombinant Adeno-Associated Virus Serotype 6 Vectors following Intravenous Delivery. J. Virol. 82: 7711-7715 [Abstract] [Full Text]  
  • Lin, J., Zhi, Y., Mays, L., Wilson, J. M. (2007). Vaccines Based on Novel Adeno-Associated Virus Vectors Elicit Aberrant CD8+ T-Cell Responses in Mice. J. Virol. 81: 11840-11849 [Abstract] [Full Text]  
  • Allocca, M., Mussolino, C., Garcia-Hoyos, M., Sanges, D., Iodice, C., Petrillo, M., Vandenberghe, L. H., Wilson, J. M., Marigo, V., Surace, E. M., Auricchio, A. (2007). Novel Adeno-Associated Virus Serotypes Efficiently Transduce Murine Photoreceptors. J. Virol. 81: 11372-11380 [Abstract] [Full Text]  
  • Xin, K.-Q., Mizukami, H., Urabe, M., Toda, Y., Shinoda, K., Yoshida, A., Oomura, K., Kojima, Y., Ichino, M., Klinman, D., Ozawa, K., Okuda, K. (2006). Induction of Robust Immune Responses against Human Immunodeficiency Virus Is Supported by the Inherent Tropism of Adeno-Associated Virus Type 5 for Dendritic Cells. J. Virol. 80: 11899-11910 [Abstract] [Full Text]  
  • Wu, Z., Asokan, A., Grieger, J. C., Govindasamy, L., Agbandje-McKenna, M., Samulski, R. J. (2006). Single Amino Acid Changes Can Influence Titer, Heparin Binding, and Tissue Tropism in Different Adeno-Associated Virus Serotypes. J. Virol. 80: 11393-11397 [Abstract] [Full Text]  
  • Wu, Z., Miller, E., Agbandje-McKenna, M., Samulski, R. J. (2006). {alpha}2,3 and {alpha}2,6 N-Linked Sialic Acids Facilitate Efficient Binding and Transduction by Adeno-Associated Virus Types 1 and 6.. J. Virol. 80: 9093-9103 [Abstract] [Full Text]  
  • Ye, C., Qiu, J., Pintel, D. J. (2006). Efficient expression of the adeno-associated virus type 5 p41 capsid gene promoter in 293 cells does not require rep.. J. Virol. 80: 6559-6567 [Abstract] [Full Text]  
  • Jiang, H., Lillicrap, D., Patarroyo-White, S., Liu, T., Qian, X., Scallan, C. D., Powell, S., Keller, T., McMurray, M., Labelle, A., Nagy, D., Vargas, J. A., Zhou, S., Couto, L. B., Pierce, G. F. (2006). Multiyear therapeutic benefit of AAV serotypes 2, 6, and 8 delivering factor VIII to hemophilia A mice and dogs. Blood 108: 107-115 [Abstract] [Full Text]  
  • Qiu, J., Cheng, F., Pintel, D. J. (2006). Expression profiles of bovine adeno-associated virus and avian adeno-associated virus display significant similarity to that of adeno-associated virus type 5.. J. Virol. 80: 5482-5493 [Abstract] [Full Text]  
  • Schmidt, M., Grot, E., Cervenka, P., Wainer, S., Buck, C., Chiorini, J. A. (2006). Identification and Characterization of Novel Adeno-Associated Virus Isolates in ATCC Virus Stocks.. J. Virol. 80: 5082-5085 [Abstract] [Full Text]  
  • Wang, Z., Zhu, T., Rehman, K. K., Bertera, S., Zhang, J., Chen, C., Papworth, G., Watkins, S., Trucco, M., Robbins, P. D., Li, J., Xiao, X. (2006). Widespread and Stable Pancreatic Gene Transfer by Adeno-Associated Virus Vectors via Different Routes.. Diabetes 55: 875-884 [Abstract] [Full Text]  
  • Scallan, C. D., Jiang, H., Liu, T., Patarroyo-White, S., Sommer, J. M., Zhou, S., Couto, L. B., Pierce, G. F. (2006). Human immunoglobulin inhibits liver transduction by AAV vectors at low AAV2 neutralizing titers in SCID mice. Blood 107: 1810-1817 [Abstract] [Full Text]  
  • Lochrie, M. A., Tatsuno, G. P., Christie, B., McDonnell, J. W., Zhou, S., Surosky, R., Pierce, G. F., Colosi, P. (2006). Mutations on the External Surfaces of Adeno-Associated Virus Type 2 Capsids That Affect Transduction and Neutralization. J. Virol. 80: 821-834 [Abstract] [Full Text]  
  • Grimm, D., Pandey, K., Nakai, H., Storm, T. A., Kay, M. A. (2006). Liver Transduction with Recombinant Adeno-Associated Virus Is Primarily Restricted by Capsid Serotype Not Vector Genotype. J. Virol. 80: 426-439 [Abstract] [Full Text]  
  • Arbetman, A. E., Lochrie, M., Zhou, S., Wellman, J., Scallan, C., Doroudchi, M. M., Randlev, B., Patarroyo-White, S., Liu, T., Smith, P., Lehmkuhl, H., Hobbs, L. A., Pierce, G. F., Colosi, P. (2005). Novel Caprine Adeno-Associated Virus (AAV) Capsid (AAV-Go.1) Is Closely Related to the Primate AAV-5 and Has Unique Tropism and Neutralization Properties. J. Virol. 79: 15238-15245 [Abstract] [Full Text]  
  • Zhu, T., Zhou, L., Mori, S., Wang, Z., McTiernan, C. F., Qiao, C., Chen, C., Wang, D. W., Li, J., Xiao, X. (2005). Sustained Whole-Body Functional Rescue in Congestive Heart Failure and Muscular Dystrophy Hamsters by Systemic Gene Transfer. Circulation 112: 2650-2659 [Abstract] [Full Text]  
  • Le Meur, G., Weber, M., Pereon, Y., Mendes-Madeira, A., Nivard, D., Deschamps, J.-Y., Moullier, P., Rolling, F. (2005). Postsurgical Assessment and Long-term Safety of Recombinant Adeno-Associated Virus-Mediated Gene Transfer Into the Retinas of Dogs and Primates. Arch Ophthalmol 123: 500-506 [Abstract] [Full Text]  
  • Johnson, P. R., Schnepp, B. C., Connell, M. J., Rohne, D., Robinson, S., Krivulka, G. R., Lord, C. I., Zinn, R., Montefiori, D. C., Letvin, N. L., Clark, K. R. (2005). Novel Adeno-Associated Virus Vector Vaccine Restricts Replication of Simian Immunodeficiency Virus in Macaques. J. Virol. 79: 955-965 [Abstract] [Full Text]  
  • Sandalon, Z., Bruckheimer, E. M., Lustig, K. H., Rogers, L. C., Peluso, R. W., Burstein, H. (2004). Secretion of a TNFR:Fc Fusion Protein following Pulmonary Administration of Pseudotyped Adeno-Associated Virus Vectors. J. Virol. 78: 12355-12365 [Abstract] [Full Text]  
  • Paterna, J.-C., Feldon, J., Bueler, H. (2004). Transduction Profiles of Recombinant Adeno-Associated Virus Vectors Derived from Serotypes 2 and 5 in the Nigrostriatal System of Rats. J. Virol. 78: 6808-6817 [Abstract] [Full Text]  
  • Schmidt, M., Katano, H., Bossis, I., Chiorini, J. A. (2004). Cloning and Characterization of a Bovine Adeno-Associated Virus. J. Virol. 78: 6509-6516 [Abstract] [Full Text]  
  • Rabinowitz, J. E., Bowles, D. E., Faust, S. M., Ledford, J. G., Cunningham, S. E., Samulski, R. J. (2004). Cross-Dressing the Virion: the Transcapsidation of Adeno-Associated Virus Serotypes Functionally Defines Subgroups. J. Virol. 78: 4421-4432 [Abstract] [Full Text]  
  • Arruda, V. R., Schuettrumpf, J., Herzog, R. W., Nichols, T. C., Robinson, N., Lotfi, Y., Mingozzi, F., Xiao, W., Couto, L. B., High, K. A. (2004). Safety and efficacy of factor IX gene transfer to skeletal muscle in murine and canine hemophilia B models by adeno-associated viral vector serotype 1. Blood 103: 85-92 [Abstract] [Full Text]  
  • Grimm, D., Zhou, S., Nakai, H., Thomas, C. E., Storm, T. A., Fuess, S., Matsushita, T., Allen, J., Surosky, R., Lochrie, M., Meuse, L., McClelland, A., Colosi, P., Kay, M. A. (2003). Preclinical in vivo evaluation of pseudotyped adeno-associated virus vectors for liver gene therapy. Blood 102: 2412-2419 [Abstract] [Full Text]  
  • Bossis, I., Chiorini, J. A. (2003). Cloning of an Avian Adeno-Associated Virus (AAAV) and Generation of Recombinant AAAV Particles. J. Virol. 77: 6799-6810 [Abstract] [Full Text]  
  • Opie, S. R., Warrington, K. H. Jr., Agbandje-McKenna, M., Zolotukhin, S., Muzyczka, N. (2003). Identification of Amino Acid Residues in the Capsid Proteins of Adeno-Associated Virus Type 2 That Contribute to Heparan Sulfate Proteoglycan Binding. J. Virol. 77: 6995-7006 [Abstract] [Full Text]  
  • Passini, M. A., Watson, D. J., Vite, C. H., Landsburg, D. J., Feigenbaum, A. L., Wolfe, J. H. (2003). Intraventricular Brain Injection of Adeno-Associated Virus Type 1 (AAV1) in Neonatal Mice Results in Complementary Patterns of Neuronal Transduction to AAV2 and Total Long-Term Correction of Storage Lesions in the Brains of {beta}-Glucuronidase-Deficient Mice. J. Virol. 77: 7034-7040 [Abstract] [Full Text]  
  • Gao, G., Alvira, M. R., Somanathan, S., Lu, Y., Vandenberghe, L. H., Rux, J. J., Calcedo, R., Sanmiguel, J., Abbas, Z., Wilson, J. M. (2003). Adeno-associated viruses undergo substantial evolution in primates during natural infections. Proc. Natl. Acad. Sci. USA 100: 6081-6086 [Abstract] [Full Text]  
  • Hauck, B., Xiao, W. (2003). Characterization of Tissue Tropism Determinants of Adeno-Associated Virus Type 1. J. Virol. 77: 2768-2774 [Abstract] [Full Text]  
  • Bowles, D. E., Rabinowitz, J. E., Samulski, R. J. (2002). Marker Rescue of Adeno-Associated Virus (AAV) Capsid Mutants: a Novel Approach for Chimeric AAV Production. J. Virol. 77: 423-432 [Abstract] [Full Text]  
  • Qiu, J., Nayak, R., Tullis, G. E., Pintel, D. J. (2002). Characterization of the Transcription Profile of Adeno-Associated Virus Type 5 Reveals a Number of Unique Features Compared to Previously Characterized Adeno-Associated Viruses. J. Virol. 76: 12435-12447 [Abstract] [Full Text]  
  • Rooney, C. P., Denning, G. M., Davis, B. P., Flaherty, D. M., Chiorini, J. A., Zabner, J. (2002). Bronchoalveolar Fluid Is Not a Major Hindrance to Virus-Mediated Gene Therapy in Cystic Fibrosis. J. Virol. 76: 10437-10443 [Abstract] [Full Text]  
  • Gao, G.-P., Alvira, M. R., Wang, L., Calcedo, R., Johnston, J., Wilson, J. M. (2002). Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc. Natl. Acad. Sci. USA 99: 11854-11859 [Abstract] [Full Text]  
  • Xie, Q., Bu, W., Bhatia, S., Hare, J., Somasundaram, T., Azzi, A., Chapman, M. S. (2002). The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy. Proc. Natl. Acad. Sci. USA 99: 10405-10410 [Abstract] [Full Text]  
  • Mastakov, M. Y., Baer, K., Symes, C. W., Leichtlein, C. B., Kotin, R. M., During, M. J. (2002). Immunological Aspects of Recombinant Adeno-Associated Virus Delivery to the Mammalian Brain. J. Virol. 76: 8446-8454 [Abstract] [Full Text]  
  • Yang, G. S., Schmidt, M., Yan, Z., Lindbloom, J. D., Harding, T. C., Donahue, B. A., Engelhardt, J. F., Kotin, R., Davidson, B. L. (2002). Virus-Mediated Transduction of Murine Retina with Adeno-Associated Virus: Effects of Viral Capsid and Genome Size. J. Virol. 76: 7651-7660 [Abstract] [Full Text]  
  • Rabinowitz, J. E., Rolling, F., Li, C., Conrath, H., Xiao, W., Xiao, X., Samulski, R. J. (2002). Cross-Packaging of a Single Adeno-Associated Virus (AAV) Type 2 Vector Genome into Multiple AAV Serotypes Enables Transduction with Broad Specificity. J. Virol. 76: 791-801 [Abstract] [Full Text]  
  • Auricchio, A., Kobinger, G., Anand, V., Hildinger, M., O'Connor, E., Maguire, A. M., Wilson, J. M., Bennett, J. (2001). Exchange of surface proteins impacts on viral vector cellular specificity and transduction characteristics: the retina as a model. Hum Mol Genet 10: 3075-3081 [Abstract] [Full Text]  
  • Ponnazhagan, S., Curiel, D. T., Shaw, D. R., Alvarez, R. D., Siegal, G. P. (2001). Adeno-associated Virus for Cancer Gene Therapy. Cancer Res. 61: 6313-6321 [Full Text]  
  • Duan, D., Yan, Z., Yue, Y., Ding, W., Engelhardt, J. F. (2001). Enhancement of Muscle Gene Delivery with Pseudotyped Adeno-Associated Virus Type 5 Correlates with Myoblast Differentiation. J. Virol. 75: 7662-7671 [Abstract] [Full Text]  
  • Kaludov, N., Brown, K. E., Walters, R. W., Zabner, J., Chiorini, J. A. (2001). Adeno-Associated Virus Serotype 4 (AAV4) and AAV5 Both Require Sialic Acid Binding for Hemagglutination and Efficient Transduction but Differ in Sialic Acid Linkage Specificity. J. Virol. 75: 6884-6893 [Abstract] [Full Text]  
  • Halbert, C. L., Allen, J. M., Miller, A. D. (2001). Adeno-Associated Virus Type 6 (AAV6) Vectors Mediate Efficient Transduction of Airway Epithelial Cells in Mouse Lungs Compared to That of AAV2 Vectors. J. Virol. 75: 6615-6624 [Abstract] [Full Text]  
  • Hildinger, M., Auricchio, A., Gao, G., Wang, L., Chirmule, N., Wilson, J. M. (2001). Hybrid Vectors Based on Adeno-Associated Virus Serotypes 2 and 5 for Muscle-Directed Gene Transfer. J. Virol. 75: 6199-6203 [Abstract] [Full Text]  
  • Lukashov, V. V., Goudsmit, J. (2001). Evolutionary Relationships among Parvoviruses: Virus-Host Coevolution among Autonomous Primate Parvoviruses and Links between Adeno-Associated and Avian Parvoviruses. J. Virol. 75: 2729-2740 [Abstract] [Full Text]  
  • Handa, A., Muramatsu, S.-i., Qiu, J., Mizukami, H., Brown, K. E. (2000). Adeno-associated virus (AAV)-3-based vectors transduce haematopoietic cells not susceptible to transduction with AAV-2-based vectors. J. Gen. Virol. 81: 2077-2084 [Abstract] [Full Text]  
  • RICHTER, M., IWATA, A., NYHUIS, J., NITTA, Y., MILLER, A. D., HALBERT, C. L., ALLEN, M. D. (2000). Adeno-associated virus vector transduction of vascular smooth muscle cells in vivo. Physiol. Genomics 2: 117-127 [Abstract] [Full Text]  
  • Zabner, J., Seiler, M., Walters, R., Kotin, R. M., Fulgeras, W., Davidson, B. L., Chiorini, J. A. (2000). Adeno-Associated Virus Type 5 (AAV5) but Not AAV2 Binds to the Apical Surfaces of Airway Epithelia and Facilitates Gene Transfer. J. Virol. 74: 3852-3858 [Abstract] [Full Text]  
  • Moskalenko, M., Chen, L., van Roey, M., Donahue, B. A., Snyder, R. O., Mcarthur, J. G., Patel, S. D. (2000). Epitope Mapping of Human Anti-Adeno-Associated Virus Type 2 Neutralizing Antibodies: Implications for Gene Therapy and Virus Structure. J. Virol. 74: 1761-1766 [Abstract] [Full Text]  
  • Halbert, C. L., Rutledge, E. A., Allen, J. M., Russell, D. W., Miller, A. D. (2000). Repeat Transduction in the Mouse Lung by Using Adeno-Associated Virus Vectors with Different Serotypes. J. Virol. 74: 1524-1532 [Abstract] [Full Text]  
  • Russell, D. W., Kay, M. A. (1999). Adeno-Associated Virus Vectors and Hematology. Blood 94: 864-874 [Full Text]  
  • Xiao, W., Chirmule, N., Berta, S. C., McCullough, B., Gao, G., Wilson, J. M. (1999). Gene Therapy Vectors Based on Adeno-Associated Virus Type 1. J. Virol. 73: 3994-4003 [Abstract] [Full Text]  
  • Chiorini, J. A., Afione, S., Kotin, R. M. (1999). Adeno-Associated Virus (AAV) Type 5 Rep Protein Cleaves a Unique Terminal Resolution Site Compared with Other AAV Serotypes. J. Virol. 73: 4293-4298 [Abstract] [Full Text]  
  • Urabe, M., Hasumi, Y., Kume, A., Surosky, R. T., Kurtzman, G. J., Tobita, K., Ozawa, K. (1999). Charged-to-Alanine Scanning Mutagenesis of the N-Terminal Half of Adeno-Associated Virus Type 2 Rep78 Protein. J. Virol. 73: 2682-2693 [Abstract] [Full Text]  
  • Bantel-Schaal, U., Delius, H., Schmidt, R., zur Hausen, H. (1999). Human Adeno-Associated Virus Type 5 Is Only Distantly Related to Other Known Primate Helper-Dependent Parvoviruses. J. Virol. 73: 939-947 [Abstract] [Full Text]  
  • Chiorini, J. A., Kim, F., Yang, L., Kotin, R. M. (1999). Cloning and Characterization of Adeno-Associated Virus Type 5. J. Virol. 73: 1309-1319 [Abstract] [Full Text]  
  • Walters, R. W., Yi, S. M. P., Keshavjee, S., Brown, K. E., Welsh, M. J., Chiorini, J. A., Zabner, J. (2001). Binding of Adeno-associated Virus Type 5 to 2,3-Linked Sialic Acid Is Required for Gene Transfer. J. Biol. Chem. 276: 20610-20616 [Abstract] [Full Text]